Background
==========

Deferoxamine is an iron-chelating agent used to treat chronic iron overload in patients with thalassemia major and other hematologic conditions requiring routine blood transfusion \[[@B1],[@B2]\]. The incidence of deferoxamine-related ocular toxicity is approximately 1.2% based on a prior study \[[@B3]\]. The clinical presentations may include night blindness, centrocaecal scotoma, constricted peripheral visual field, pigmentary retinopathy, and optic neuropathy \[[@B3]\]. Retinal pigmentary change was most frequently reported \[[@B4]\]. This case report pathologically characterizes the spectral domain optical coherence tomography (SD-OCT, SPECTRALIS SD-OCT, Heidelberg, Germany) and near-infrared reflectance (NIR) findings in a patient with deferoxamine retinopathy.

Case presentation
=================

A 34-year-old Taiwanese man with beta-thalassemia major had been administered routine blood transfusion and subcutaneous deferoxamine at 30 mg/kg/day for 20 years since youth. He was hospitalized for a compression fracture and myelopathy of the thoracic spine. He presented with acute onset of decreased vision, impaired color vision, and night blindness following continuous intravenous deferoxamine (98 mg/kg) for 42 days for the treatment of elevated serum ferritin level. On ophthalmic examinations, the best-corrected vision was 20/200 in the right eye and 20/40 in the left eye. The intraocular pressure measurement and anterior segment examination yielded normal results for both eyes. The fundus examination revealed multiple discrete hypo-pigmented circular lesions over the posterior pole and mid-peripheral retina in both eyes.Deferoxamine retinopathy was suspected, and the patient was switched to oral deferasirox/deferiprone. Six weeks later, there was an improvement in the best-corrected vision (20/60 in the right eye and 20/25 in the left eye) and color vision. Retinal pigmentary changes became confluent (Figure [1](#F1){ref-type="fig"}). NIR showed hyper-reflective deposits particularly in the parafoveal and perifoveal areas (Figure [2](#F2){ref-type="fig"}). SD-OCT showed multiple confluent hyper-reflective deposits in the choroid, retinal pigment epithelium (RPE) and IS/OS junction. Thickened RPE, Bruch's membrane, and choroid space were also discovered. The IS/OS junction was most severely disrupted at the perifoveal and parafoveal areas than at the foveola area (Figure [3](#F3){ref-type="fig"}).

![**Dilated fundus examination at the 6-week follow-up visit.** A dilated fundus examination revealed diffuse and confluent hypo-pigmented pinpoint lesions extending from the posterior pole (arrow) to the peripheral retina (arrowhead).](1471-2415-14-88-1){#F1}

![**Near-infrared reflectance (NIR) at the 6-week re-examination.** NIR showed hyper-reflective deposits particularly in the parafoveal and perifoveal areas.](1471-2415-14-88-2){#F2}

![**SD-OCT at the 6-week re-examination.** SD-OCT revealed a disrupted IS/OS junction (arrow) and multiple diffuse and confluent hyper-reflective deposits in the retinal pigment epithelium (RPE), IS/OS junction, and choroid (arrowhead). Thickened RPE, Bruch's membrane, and choroidal space were also observed.](1471-2415-14-88-3){#F3}

Conclusion
==========

Deferoxamine is a widely used chelating agent in treating transfusional hemochromatosis \[[@B1],[@B5]\]. Visual symptoms included decreased visual acuity, night blindness, and colour vision abnormalities \[[@B2]-[@B6]\]. These ophthalmic examination findings have been reported extensively. Sumu et al. observed speckled hyper-fluorescence with well-demarcated areas of blocked fluorescence on fluorescein angiography \[[@B6]\]. Markedly reduced photopic, scotopic, and 30-Hz flicker response amplitudes were reported on electroretinograms. Electro-oculogram typically showed reduced light-peak to dark-trough ratios \[[@B4],[@B6]\]. Viola et al. reported abnormal fundus autofluorescence in 9% of 197 patients, but only 5 patients reported visual symptoms \[[@B7]\]. Viola et al. further described the pattern dystrophy--like or minimal changes of macular lesions in patients with deferoxamine retinopathy by using NIR and SD-OCT which pointed out the disease itself affects the RPE--Bruch membrane--photoreceptor complex \[[@B8]\].

The pathophysiology of deferoxamine-related retinopathy has been investigated for several years. Rahi et al. first reported electron microscopic findings of deferoxamine retinopathy, including patchy RPE depigmentation, abnormally thickened Bruch\'s membrane, and normal photoreceptors \[[@B9]\]. Previous studies also discovered that iron overload and iron-chelating agents both may be mutually confounding factors in the causation of ocular changes of thalassemia such as RPE mottling \[[@B5],[@B10]-[@B13]\]. The SD-OCT findings in our case revealed multiple confluent hyper-reflective deposits in the RPE, IS/OS junction and choroid (Figure [3](#F3){ref-type="fig"}). We hypothesized that hyper-reflective deposits detected by means of SD-OCT may represent a primarily involvement of RPE--Bruch membrane--photoreceptor complex in deferoxamine toxicity which correlated with previous histologic findings \[[@B8],[@B9]\].

Ocular deferoxamine toxicity could cause vision impairment; regular ophthalmic assessment is required in these patients. We presented the SD-OCT findings of deferoxamine retinopathy highly correlated with previous histologic descriptions and showed that the toxicity primarily involved the RPE--Bruch membrane--photoreceptor complex. Noninvasive SD-OCT and NIR imaging, both well tolerated by patients, may be helpful in early detection and long-term monitoring.
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SD-OCT: Spectral domain optical coherence tomography; IS/OS: Inner segment/outer segment; RPE: Retinal pigment epithelium.

Competing interests
===================

The authors declare that they have no competing interests.

Authors' contributions
======================

C-HW conducted the literature search and composed the manuscript. Y-HC conceived the idea for the manuscript, conducted a literature search, and critiqued the manuscript. All authors read and approved the final manuscript.

Pre-publication history
=======================

The pre-publication history for this paper can be accessed here:

<http://www.biomedcentral.com/1471-2415/14/88/prepub>

Acknowledgements
================

The authors thank Dr. Chao-Ping Yang from the Department of Pediatrics, Chang Gung Memorial Hospital, in Taoyuan, Taiwan for her expertise in managing this patient.
